Raymond James Financial Adds Two New Directors

Raymond James Financial, Inc. (NYSE: RJF) has appointed two new directors to its Board of Directors. Cecily Mistarz, the former Executive Vice President and U.S. Chief Risk Officer of BMO Financial Group, and Raymond James President and CFO Paul Shoukry have been elected as new directors, increasing the board's size from 11 to 13 members.

Cecily Mistarz, 62, brings extensive risk management experience to the board, having served at BMO from September 2014 until her retirement in April 2021, overseeing the risk function for an intermediate holding company and a nationally chartered bank. She will serve on the board’s Audit Committee and Risk Committee and holds a bachelor’s degree in economics from Bradley University and an MBA from the University of Chicago.

Paul Shoukry, 41, has been with Raymond James since 2010 and has served as CFO since 2020. He will succeed the current CEO, Paul Reilly, in fiscal year 2025. Shoukry is currently responsible for the overall financial management of the company and oversees the firm’s Bank segment, among other roles. He earned an MBA with honors from Columbia University and graduated magna cum laude with a bachelor’s and masters degree of Accountancy from The University of Georgia.

Raymond James Financial, Inc. is a leading diversified financial services company providing private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities. The company has approximately 8,800 financial advisors, and total client assets are reported at $1.45 trillion. The firm has been public since 1983 and is listed on the New York Stock Exchange under the symbol RJF. As a result of these announcements, the company's shares have moved 1.8% on the market, and are now trading at a price of $125.59. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.